UMIN-CTR History

Name：　　UMIN ID：


Unique ID issued by UMIN UMIN000037090
Receipt number R000042121
Scientific Title Real world evidence of long-term safety and efficacy in patients treated with durvalumab after concurrent chemoradiation for unresectable stage III NSCLC ;AYAME study
Date of disclosure of the study information 2019/06/17
Last modified on 2023/10/24 14:08:29

No. Disposal Last modified on Item of update
1 Insert 2019/06/17 15:21:20
2 Update 2019/10/01 10:45:14 Recruitment status
Date of IRB
3 Update 2020/06/11 20:19:30 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
4 Update 2020/06/11 20:37:35 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
5 Update 2020/06/11 20:44:11
Last name of contact person

Last name of contact person
Division name
Division name
Division name
Division name
Institute
6 Update 2020/06/11 20:46:11 Anticipated trial start date
Last follow-up date
7 Update 2020/06/11 20:50:10 Primary outcomes
Key secondary outcomes
8 Update 2020/06/15 11:10:18 Primary outcomes
9 Update 2020/06/15 11:11:19 Other related information
10 Update 2021/01/19 14:57:29 Recruitment status
11 Update 2021/06/28 12:29:59 Name of person sending information
Name of person sending information
Research ethics review
12 Update 2021/06/28 12:34:54 Organization1
Address1
Organization
Organization
Address
Address
13 Update 2021/11/15 15:56:36 Institutions
14 Update 2022/05/10 10:50:45 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Email
15 Update 2023/01/11 17:16:40 Publication of results
Number of participants that the trial has enrolled
16 Update 2023/07/05 10:56:16 Division name
Division name
17 Update 2023/10/24 11:52:08 Division name
Division name
Email
18 Update 2023/10/24 12:09:16 Last follow-up date
Date of closure to data entry
Date trial data considered complete
19 Update 2023/10/24 14:08:29 Date analysis concluded